The global live attenuated vaccines market is projected to grow at a CAGR of over 10.0% during the forecast period (2020-2027). Live attenuated vaccines are made by utilizing stable mutations to weaken bacterial or viral strains. The microbe is not killed by this technique and it disables the microorganism's capacity to cause illness. The immune system of a vaccinated person is elicited by the live attenuated vaccination. Tuberculosis, yellow fever, retroviral, measles, polio, and other illnesses are all prevented by live attenuated vaccinations. Government initiatives in many nations have resulted in a considerable reduction in the number of cases of polio across the globe.

The most common method for vaccine production is live attenuation. The market is driven by benefits offered by live attenuated vaccines such as oral route of administration, cost-effective manufacturing, long-lasting, and high efficacy. Tuberculosis is one of the top 10 killers across the globe. Live attenuated vaccines are used for preventing various diseases. For instance, in the UK, it is used for the Rotavirus vaccine, Nasal flu vaccine, and BCG vaccine against TB (special groups only), among others. 

In 2019, the number of people notified of TB in England rose from 4,615 in 2018 to 4,725 in 2019, a rise of 2.4%. Most people notified with TB were concentrated in major urban centers. London accounted for over a third of cases. Whilst the number of UK-born cases fell by 5%, the number of cases born outside the UK increased by 4%. This group accounted for 74% of TB cases in 2019. The increasing cases will significantly drive the demand for vaccines and hence will drive the growth of the global live attenuated vaccines market.

Market Coverage

• The market number available for – 2019-2027
• Base year- 2019
• Forecast period- 2020-2027
• Segment Covered- 

o By Product Type – Bacterial, Viral

o By Development – Tissue Culture, Embryonated Eggs, Live Animals

• Competitive Landscape: GlaxoSmithKline plc, Daiichi Sankyo Company, Limited, AstraZeneca, Biological E, SutroVax Inc, Polymun Scientific, Boehringer Ingelheim International GmbH, Merck & Co., Inc., Sanaria, Sanofi, and Emergent BioSolutions Inc., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Live Attenuated Vaccines Market Report 

By Product Type

• Bacterial
• Viral

By Development

• Tissue Culture
• Embryonated Eggs
• Live Animals

By Region